Bevacizumab, radiation therapy (RT) and temozolomide followed by bevacizumab and temozolomide with continuation of bevacizumab beyond progression: A phase II trial.

Conference Paper


Full Text

Duke Authors

Cited Authors

  • Weant, M; Dunn-Pirio, A; Peters, K; Vlahovic, G; Randazzo, D; Herndon, J; Healy, P; Threatt, S; Sampson, J; Friedman, A; Friedman, H; Desjardins, A

Duke Editors

Duke Contributors

Published In

Volume / Issue

  • 17 / Suppl. 5, abstr. ATCT-13

Published By

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nov206.13

Conference Name

  • 20th Annual Scientific Meeting and Educations Day of the Society for Neuro-Oncology

Conference Location

  • San Antonio, TX

Conference Start Date

  • November 19, 2015

Conference End Date

  • November 22, 2015